Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 288-927-9 | CAS number: 85940-40-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
There are no studies available in which the toxicokinetic properties of the test substance were investigated. Based on the absence of adverse findings in toxicity studies and slight changes in liver weight indicating bioavailability and probably metabolism, a potential for bioaccumulation is unlikely.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
There are no studies available in which the toxicokinetic properties of the test substance were investigated. Based on the absence of adverse findings in toxicity studies and slight changes in liver weight indicating bioavailability and probably metabolism, a potential for bioaccumulation is unlikely. Further details for this assessments are given below.
Chemistry
The test substance is a viscous UVCB of tall oil fatty acids with pentaethylenehexamine those water solubility (deionised water) is 5 - 19 mg/l. The material is a honey-like liquid with no definite logPow. Also a definite molecular weight of the substance does not exist (UVCB), the range of the molecular weight is from minimum 232 Da (reactant) to 1351 Da (modified fatty acid). The test material is not expected to be surface active.
Absorption
In acute oral and dermal toxicity studies, rats were administered to the test substance. No mortalities or clinical signs of toxicity were observed at dose levels of 2000 mg/kg bw, indicating primarily a very low level of oral and dermal toxicity. The NOAEL in male and female rats in a subacute oral repeated dose study (OECD guideline 422) is 100 mg/kg bw due to liver effects. The high molecular weight of the modified fatty acid-complexes (500 - 780 Da) may hamper gastrointestinal absorption. On the other hand, lower liver weight and increased enzyme level (ALAT, ASAT) indicate that the substance is bioavailable. The single fatty acids of the UVCB mixture for exemple may be taken up via micelles with bile acids.
Based on a model calculation (Fitzpatrick, et al., 2004) the substance is slightly skin permeable. This calculation is based on the log Pow and molecular weight of substances. Since the target substance is an UVCB, it has no definite logPow and the molecular weight ranges from minimum 232 Da (reactant) to 1351 Da (modified fatty acid). Therefore, the above mentioned result is of limited relevance.
The test substance is a highly viscous material and decomposes before boiling. This indicates that absorption of the substance via vapour inhalation is not relevant.
Metabolism
Single oral application of the test item to male and female rats did not provoke any effect up to 14 days post observation period. Subacute oral administration of the test substance to Wistar rats at doses of 30, 100 and 300 mg/kg/day resulted in reduced food consumption and subsequently slightly decreased body weight in the high dose group. In addition increased ALAT and ASAT levels as well as lower liver weight were observed in the 300 mg/kg bw animals. Based on the results of this study, 100 mg/kg/day was considered to be the no observed-adverse-effect-level (NOAEL).
As mentioned before, the test material is an UVCB and consists of several compounds and reaction products. It is therefore difficult to make a detailed statement on the phase I and II metabolism. Fatty acids in general are metabolized by conjugation with acetyl-CoA and subsequent beta-oxidation. Excessive fatty acid uptake results in lipid storage. Though, an increase in body weight, changes in food consumption or fatty changes in tissues and organs were not observed. This indicates that only a small part of the fatty acids are taken up (bolus effect) or the whole substrate is degradated and metabolized. The reaction products consisting of fatty acids and pentaethylenehexamine are presumbly initially degradated by gastrointestinal bacteria (shortening of fatty acid chains). The downsized compound then can be absorbed and metabolized by hydroxylation of the fatty acid chain residues. Subsequent conjugation by UGT and SULT and excretion via feces and urine seems plausible. Reaction products of high molecular weight (> 500 g/mol) are most likely not absorbed but exreted unchanged.
Dermal application caused skin irritation in rats and rabbits, signs of systemic toxicity were not observed which suggests that the test item induces primarily local effects. Besides tall oil fatty acids pentaethylenehexamine is another edukt of the chemical reaction. This substance is legally classified as corrosive (and skin sensitizing). Remaining edukt may be responsible for the local irritating effects.
Excretion
As described above, high molecular weight components of the UVCB are expected to be excreted unchanged via the feces. In case of gastrointestinal uptake and metabolism through hydroxylation and conjucation it is expected that the test substances might be excreted in urine and feces. Small metabolites like pentaethylenehexamine will be excreted via urine. Overall, the test material is not expected to accumulate in the body.
Used references:
Fitzpatrick, D., et al. (2004). "Modelling skin permeability in risk assessment-the future." Chemosphere 55 (10): 1309-14.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.